G Medical Innovations Holdings Ltd (GMVDF)
OTCMKTS: GMVDF · Delayed Price · USD
0.0200
+0.0030 (17.65%)
Apr 26, 2024, 4:00 PM EDT - Market closed

GMVDF Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2022202120202019
Market Capitalization
1222--
Market Cap Growth
--89.84%---
Enterprise Value
2425213
PE Ratio
0.170.171.56--
PS Ratio
0.170.524.53--
PB Ratio
-0.31-0.31-3.73--
P/FCF Ratio
-0.11-0.11-1.88--
P/OCF Ratio
-0.12-0.12-1.96--
EV/Sales Ratio
0.500.844.990.402.42
EV/EBITDA Ratio
0.090.151.220.130.65
EV/EBIT Ratio
0.100.161.310.150.75
EV/FCF Ratio
-0.18-0.18-2.07-0.38-1.99
Debt / Equity Ratio
-0.28-0.28-1.41-0.45-1.05
Debt / EBITDA Ratio
0.090.090.420.190.68
Debt / FCF Ratio
-0.10-0.10-0.71-0.55-2.09
Quick Ratio
0.210.211.020.390.12
Current Ratio
0.220.221.030.400.14
Asset Turnover
0.580.580.620.69-
Interest Coverage
2.442.444.2217.694.95
Return on Equity (ROE)
-202.00%-202.00%-234.50%-127.40%-
Return on Assets (ROA)
176.30%176.30%181.10%176.30%-
Return on Capital (ROIC)
419.82%419.82%-446.13%357.66%-1927.83%
Earnings Yield
1771.52%591.63%64.29%--
FCF Yield
-2694.68%-899.94%-53.27%--
Buyback Yield / Dilution
-243.15%-122.18%-54.45%95.12%-
Total Shareholder Return
-243.15%-122.18%-54.45%95.12%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).